Journal of Nutrition and Metabolism, published by HINDAWI LTD, is a prominent peer-reviewed, open-access journal that has been serving the scientific community since 2010. Based in Egypt, this journal is dedicated to advancing the field of nutrition and metabolism, providing a platform for innovative research that spans endocrinology, diabetes, food science, and dietetics. With a consistent commitment to accessibility, it embraces open-access policies to facilitate wider dissemination of knowledge, ensuring that researchers, professionals, and students can freely engage with pivotal studies and findings. The journal is currently indexed with an impressive standing in various categories, including being positioned in Q2 in Food Science and Q3 in Endocrinology, Diabetes and Metabolism. Furthermore, it ranks among the top journals in its fields on Scopus, reflecting its significance and impact within the research community. With a focus on robust, evidence-based studies that inform dietary practices and metabolic health, the Journal of Nutrition and Metabolism plays a crucial role in addressing the challenges of modern nutrition.

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

Pediatric Research, published by SpringerNature, is a leading journal in the field of pediatrics, perinatology, and child health. With an impressive impact factor reflecting its stature, this journal has been integral in advancing research since its inception in 1967. With a placement in the Q1 category for Pediatrics, Perinatology, and Child Health, and ranking #30 out of 330 in Scopus, Pediatric Research is recognized for its rigorous peer-review process and commitment to disseminating vital findings that impact child health globally. The journal primarily serves as a platform for researchers, healthcare professionals, and students dedicated to exploring innovative solutions to pediatric health challenges. Although not an open-access journal, it provides valuable insights and research that contribute significantly to improving health outcomes for children. Based in the United States, with a global reach, Pediatric Research remains at the forefront of pediatric innovation and scholarship through 2024 and beyond.

INTERNATIONAL JOURNAL OF OBESITY, published by SpringerNature, stands as a premier multidisciplinary platform for research in the fields of Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics, as well as Miscellaneous Medicine. With a remarkable impact, the journal is consistently positioned in the Q1 category across these critical areas, underscoring its significance in advancing the understanding of obesity and its related health outcomes. Established in 1977 and covering a broad spectrum of studies until 2024, it boasts a notable Scopus Rank reflecting its influential contributions to the scientific community, including a rank of 14 out of 140 in Nutrition and Dietetics. The INTERNATIONAL JOURNAL OF OBESITY is not just a repository of knowledge but a vital resource for researchers, clinicians, and students aiming to explore the complexities of obesity and develop evidence-based interventions. Despite not being an open-access journal, its rigorous peer-reviewed articles remain accessible to those within academic institutions, facilitating an essential dialogue among professionals dedicated to this critical global health issue.

Current Obesity Reports, an esteemed journal published by SPRINGER, serves as a pivotal platform for scholars and practitioners in the field of obesity research. With its ISSN of 2162-4968, this journal has been recognized within the competitive landscape of Medicine & Internal Medicine, achieving a commendable Scopus rank of #11 out of 167, placing it in the top 93rd percentile. Launched in 2012 and covering critical developments in obesity up to 2024, this journal synthesizes innovative research, evidence-based practices, and comprehensive reviews that cater to a diverse audience, from researchers to public health professionals. While currently not offering open access options, it remains dedicated to advancing knowledge and fostering discussions that address the multifaceted issues related to obesity, its public health implications, and treatment methodologies. For those involved in tackling obesity challenges, Current Obesity Reports stands as a vital resource, contributing significantly to the discourse and scholarship in the field.

Endocrine Metabolic & Immune Disorders-Drug Targets, published by Bentham Science Publishers, is a premier journal focused on the intricate interplay between endocrinology, metabolism, and immune response, with a particular emphasis on drug targets. Established in 2006 and set to continue its influence until 2024, this journal serves as a crucial platform for researchers and professionals to communicate significant advances in understanding metabolic and immune disorders, making it an invaluable resource in the realms of Endocrinology and Immunology. With an impact factor positioned within the Q3 category for both Endocrinology, Diabetes and Metabolism, and Immunology and Allergy as of 2023, the journal stands at the crossroads of critical research and clinical application, facilitating ongoing dialogue among the scientific community. Although currently not open access, its dedication to high-quality peer-reviewed articles ensures that cutting-edge research remains accessible to those invested in enhancing therapeutic strategies. For researchers and practitioners alike, Endocrine Metabolic & Immune Disorders-Drug Targets is an essential conduit for the latest findings that can influence treatment paradigms and bolster the understanding of complex biological systems.

Current Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.

Childhood Obesity is a leading peer-reviewed academic journal published by Mary Ann Liebert, Inc., dedicated to the critical examination of obesity issues affecting children and adolescents. Covering a range of interdisciplinary research within Endocrinology, Diabetes, and Metabolism, Nutrition and Dietetics, and Pediatrics, the journal holds prestigious rankings across multiple categories, including Q1 in Pediatrics, Perinatology, and Child Health, showcasing its impact and quality in the field. With its focus on innovative research and practical solutions, Childhood Obesity invites contributions that advance understanding and strategies for combating childhood obesity, making it an invaluable resource for researchers, healthcare professionals, and students alike. Published from 2010 to 2024, the journal remains committed to enhancing public health knowledge and practices through high-quality, evidence-based studies.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

ANALES DE PEDIATRIA is a prestigious academic journal dedicated to advancing the field of pediatrics, offering a platform for innovative research and clinical studies. Published by EDICIONES DOYMA S A in Spain, this open-access journal has been committed to disseminating impactful findings since its transition to open access in 2018, ensuring that vital pediatric research is accessible to a global audience. As of 2023, it is categorized in the third quartile (Q3) of pediatrics, perinatology, and child health, reflecting its growing influence, with a Scopus ranking of #176 out of 330 in this competitive field. Covering a wide range of topics with the goal of improving child health outcomes, ANALES DE PEDIATRIA serves as an essential resource for researchers, professionals, and students alike, invitation them to contribute and engage with the latest developments in pediatric medicine.